Khartis Therapeutics
PrivateLast Round
Series B
Aug 13, 2026
Total Funding Raised
$95M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Khartis Therapeutics is a biotechnology company that develops oral small-molecule medicines for immunological and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Khartis Therapeutics Comparables
Compare Khartis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sling Therapeutics | 86% | |
| Ethyreal Bio | 81% | |
| Yarrow Bioscience, Inc. | 81% | |
Khartis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 13, 2026 |
Khartis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forge Life Science Partners | Series B |
| Foresite Capital | Series B, Series A |
| Alexandria Venture Investments | Series B |
| Lilly Asia Ventures | Series B, Series A |
| Nextech Invest | Series B, Series A |
| Longwood Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2026
$50M round led by Forge Life Science Partners.
Khartis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Khartis Therapeutics's valuation, stock price, and market status.